Plectranthus amboinicus (Spreng.) Semi‑purified Fractions with Selective β‑Glucuronidase Inhibition Elucidated with gas chromatography‑mass spectrometry and in silico docking

ABSTRACT

Objectives: An approach to alleviating the toxic effects of these compounds is by inhibiting bacterial β‑GUS. Materials and Methods: We determined the Escherichia coli β‑GUS inhibitory activity of P. amboinicus leaves using a bioassay‑guided purification approach. The P. amboinicus chloroform extract was purified using normal‑phase column chromatography to produce several fractions. The fractions were screened for E. coli β‑GUS inhibitory activity using the 4‑Methylumbelliferyl glucuronide (4‑MUG) assay. Fractions with high activity were assayed further to determine toxicity against E. coli and selectivity compared to human β‑GUS. Highly‑active and highly‑selective fractions were further characterized using gas chromatography‑mass spectrometry (GC‑MS) and in silico docking to identify specific compounds. Results: Assay‑guided purification of the crude chloroform extract with β‑GUS inhibitory activity (IC50 = 57.8 µg/mL) yielded four fractions with high activity: Fraction‑543W (IC50 = 16.24 µg/mL), Fraction‑5231 (IC50 = 3.087 µg/mL), and Fraction‑52335A (IC50 = 12.93 μg/mL). The crude extract and fractions exhibited high selectivity for E. coli β‑GUS against human β‑GUS (P < 0.0001, α =0.05). The antimicrobial assay of fractions showed no toxic effects on E. coli. GC‑MS profiling of the active fractions identified the compounds present to be similar to essential oil extracts of P. amboinicus reported previously. Ranking of these compounds by in silico identified the compounds with high binding affinity: Phthalic acid, cyclobutyl tridecyl ester (‑7.5 kcal/mol) from Fraction‑543W, N‑Benzyl‑2‑allyl‑2‑tosyl‑4‑penten‑1‑amine (‑8.0 kcal/mol) from Fraction‑5231, and Dehydroabietic Acid (‑7.9 kcal/mol) from Fraction‑52335A. By comparing to binding modes of reported inhibitors, we show that these compounds also interact with active site residues Tyr469 and Tyr472, and with several residues in the β‑GUS bacterial loop. Conclusion: Herein, we identified highly‑active and highly‑selective E. coli β‑GUS inhibitors from P. amboinicus leaf chloroform extracts, utilizing a bioassay‑guided purification coupled by metabolomics and in silico docking approach. This is the first report on the potential of P. amboinicus as selective inhibitor of E. coli β‑GUSs.

KEYWORDS

• Escherichia coli
• gas chromatography‑mass spectrometry
• in silico docking
• Plectranthus amboinicus
• β‑glucuronidase

Showing references and in-text citations exactly as published.

• DOI10.4103/pm.pm_149_21Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 17, ISSUE 6SPharmacognosy and Pharmacology of Calotropis gigantea for Discovery of Anticancer TherapeuticsZahra Khosravi, Arun H. S. Kumar · pp. S123–S128Original ArticleSame type: Article
• Article · VOLUME 17, ISSUE 6SEvaluation of Acacia auriculiformis Benth. Leaves for Wound Healing Activity in Type 2 Diabetic RatsNaresh Kumar Rangra, Subir Samanta, Kishanta Kumar Pradhan · pp. S129–S142Original ArticleSame type: Article
• Article · VOLUME 17, ISSUE 6SEthanolic Extract of Capparis decidua Fruit Ameliorates Methotrexate‑Induced Hepatotoxicity by Suppressing Oxidative Stress and Inflammation by Modulating Nuclear Factor‑Kappa B Signaling PathwayPreetha Santhakumar, Anitha Roy, M. Karthik Ganesh, J. Selvaraj, Lavanya Prathap, Yuvaraj Babu K · pp. S143–S150Original ArticleSame type: Article
• Article · VOLUME 17, ISSUE 6SAntioxidant and Antiacetylcholinestrase Studies of In vitro Regenerated and Transformed Hairy Roots of Ocimum sanctum (L.)Annie Jessica Toppo, Sheela Chandra · pp. S151–S161Original ArticleSame type: Article